Protein Variants | Comment | Organism |
---|---|---|
additional information | aldh5a1-/- (SSADHD) mice and their genetic controls (aldh5a1+/+) are exposed to either a 4% (w/w) glutamine-containing diet or a glutamine-free diet from conception until postnatal day 30. The test diet increases hepatic glutamate in both genotypes, decreases glutamine in aldh5a1+/+ but not in aldh5a1-/-, but has no effect on GABA. Dried bloodspot analyses show significantly elevated GABA in mutants (approximately 800% above controls) and decreased glutamate (approximately 25%), but no glutamine difference with controls. Glutamine supplementation does not impact blood GABA but significantly increased glutamine and glutamate in both genotypes indicating systemic exposure to dietary glutamine. Ataxia and pronounced hyperactivity are observed in aldh5a1-/- mice but remain unchanged by the diet intervention. Glutamine supplementation improves peripheral but not central glutamine deficiency in experimental SSADHD. Murine SSADHD presents with dramatic changes in amino acid levels including a significant elevation in brain GABA, one of the major inhibitory neurotransmitters, a moderate increase in excitatory neurotransmitter glutamate, and a very significant decrease in brain glutamine, the metabolic precursor of glutamate. Phenotype, overview | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
succinate semialdehyde + NAD+ + H2O | Mus musculus | - |
succinate + NADH + 2 H+ | - |
? | |
succinate semialdehyde + NAD+ + H2O | Mus musculus C57BL/6 | - |
succinate + NADH + 2 H+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | Q8BWF0 | - |
- |
Mus musculus C57BL/6 | Q8BWF0 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Mus musculus | - |
liver | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
succinate semialdehyde + NAD+ + H2O | - |
Mus musculus | succinate + NADH + 2 H+ | - |
? | |
succinate semialdehyde + NAD+ + H2O | - |
Mus musculus C57BL/6 | succinate + NADH + 2 H+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SSADH | - |
Mus musculus |
succinic semialdehyde dehydrogenase | - |
Mus musculus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NAD+ | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | succinic semialdehyde dehydrogenase (SSADH) deficiency (SSADHD) is a heritable disorder of gamma-aminobutyric acid (GABA) metabolism associating with elevated GABA and gamma-hydroxybutyrate (GHB). The heterogeneous phenotype ranges from mild to severe, including developmental delay, movement abnormalities, neuropsychiatric morbidity, and seizures murine succinic semialdehyde dehydrogenase deficiency (SSADHD) manifests with high concentrations of gamma-aminobutyric acid (GABA) and gamma-hydroxybutyrate (GHB) and low glutamine in the brain | Mus musculus |